We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$11.8B
AUM Growth
+$11.7B
Cap. Flow
+$973M
Cap. Flow %
8.28%
Top 10 Hldgs %
24.41%
Holding
296
New
40
Increased
100
Reduced
97
Closed
30

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$166M
2
AMGN icon
Amgen
AMGN
+$123M
3
ADSK icon
Autodesk
ADSK
+$114M
4
UNH icon
UnitedHealth
UNH
+$103M
5
MRK icon
Merck
MRK
+$102M

Sector Composition

Rank Sector Weight
1 Technology 24.57%
2 Financials 22.21%
3 Healthcare 21.91%
4 Communication Services 9.53%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPGI icon
26
S&P Global
SPGI
$126B
$102M 0.87%
521,335
-395
-0.1% -$81.5K
NVDA icon
27
NVIDIA
NVDA
$5.01T
$102M 0.86%
14,460,360
+4,346,360
+43% +$28.3M
RTX icon
28
RTX Corp
RTX
$287B
$101M 0.86%
1,150,082
+34,617
+3% +$2.91M
JPM icon
29
JPMorgan Chase
JPM
$939B
$95.9M 0.82%
849,453
+9,531
+1% +$1.08M
CRM icon
30
Salesforce
CRM
$134B
$92.4M 0.79%
580,882
-13,669
-2% -$2.03M
BAC icon
31
Bank of America
BAC
$435B
$89.4M 0.76%
3,033,453
+7,540
+0.2% +$230K
WRB icon
32
W.R. Berkley
WRB
$28B
$88.6M 0.75%
3,742,875
+64,125
+2% +$1.46M
Y
33
DELISTED
Alleghany Corp
Y
$88.6M 0.75%
135,750
+5,750
+4% +$3.6M
AABA
34
DELISTED
Altaba Inc
AABA
$88.2M 0.75%
1,294,333
+253,969
+24% +$17.9M
LOXO
35
DELISTED
Loxo Oncology, Inc
LOXO
$87.3M 0.74%
511,150
-6,221
-1% -$1.05M
XLNX
36
DELISTED
Xilinx Inc
XLNX
$86.8M 0.74%
1,082,788
+127,808
+13% +$9.35M
ELV icon
37
Elevance Health
ELV
$81.9B
$84.5M 0.72%
308,396
-89,512
-22% -$23.2M
ISRG icon
38
Intuitive Surgical
ISRG
$121B
$84.1M 0.72%
439,488
+140,559
+47% +$25M
ESNT icon
39
Essent Group
ESNT
$6.06B
$78.5M 0.67%
1,775,000
+50,000
+3% +$2.05M
MHK icon
40
Mohawk Industries
MHK
$6.9B
$78M 0.66%
444,538
+38,352
+9% +$7.52M
BAH icon
41
Booz Allen Hamilton
BAH
$8.7B
$77.8M 0.66%
1,567,363
-41,645
-3% -$2.03M
AMD icon
42
Advanced Micro Devices
AMD
$851B
$77M 0.65%
2,491,584
-3,290,150
-57% -$74.2M
MA icon
43
Mastercard
MA
$477B
$75.6M 0.64%
339,527
+140,518
+71% +$29.3M
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.07T
$75.5M 0.64%
352,500
+3,363
+1% +$690K
ADBE icon
45
Adobe
ADBE
$89.5B
$75.1M 0.64%
278,238
-26,107
-9% -$6.73M
ZEN
46
DELISTED
ZENDESK INC
ZEN
$74.8M 0.64%
1,054,190
-145,246
-12% -$9.27M
MO icon
47
Altria Group
MO
$122B
$74.3M 0.63%
1,231,580
+32,971
+3% +$1.96M
EXPE icon
48
Expedia Group
EXPE
$31.2B
$73M 0.62%
559,599
-41,736
-7% -$5.42M
ABT icon
49
Abbott
ABT
$180B
$73M 0.62%
995,000
+156,870
+19% +$10.3M
ATVI
50
DELISTED
Activision Blizzard
ATVI
$72.8M 0.62%
874,860
+90,481
+12% +$6.86M

Similar funds

Polar Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Polar Capital held 296 positions worth $11.8B, up 70,685% from $16.6M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $973M of net new capital in Q3 2018, opening 40 new positions and adding to 100 existing holdings. Its largest new stake was Johnson & Johnson: 1,250,000 shares worth $173M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $78.6M trimmed.

  • Polar Capital's largest Q3 2018 buy was Johnson & Johnson: 1,250,000 shares worth $173M.
  • Polar Capital added most to UnitedHealth in Q3 2018, an estimated $103M increase.
  • Polar Capital's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $78.6M.
  • Polar Capital fully exited Amdocs in Q3 2018, selling an estimated $46.6K.
  • Polar Capital's ten largest holdings make up 24% of its $11.8B portfolio in Q3 2018.
  • Polar Capital opened 40 new positions and closed 30 in Q3 2018.
  • Polar Capital's portfolio value rose 70,685% quarter-over-quarter to $11.8B.

Based on Polar Capital's 13F filing for Q3 2018, filed 14 Nov 2018.